stromal cells. Collectively, this work establishes a structurally validated and functionally optimized anti-FAPα VHH-Fc candidates for stromal-targeted immunotherapy in solid tumors.
Sabnani et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: